Case study: the use of melatonin in a boy with refractory bipolar disorder.
The authors describe the clinical course of a 10-year-old boy with bipolar disorder diagnosed at age 5 years. Lithium, carbamazepine, and valproic acid were ineffective or caused intolerable side effects. A trial of melatonin led to rapid relief of insomnia and aborted a manic episode. He has continued to take melatonin and adjunctive alprazolam for 15 months without recurrence of insomnia or mania. Affective disorders involving circadian dysregulation may respond to interventions that restore a normal sleep-wake cycle. Literature supporting this hypothesis is cited.
Robertson
J M
JM
Department of Psychiatry, University of Louisville School of Medicine, KY, USA.
Tanguay
P E
PE
D001714:Bipolar Disorder / Q000188:drug therapy*; D002648:Child; D006801:Humans; D008297:Male; D008550:Melatonin / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D012894:Sleep Stages / Q000187:drug effects; D016896:Treatment Outcome
D008550:Melatonin